Literature DB >> 10225817

Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia.

P A Courtney1, A D Crockard, K Williamson, A E Irvine, R J Kennedy, A L Bell.   

Abstract

OBJECTIVE: To quantify the percentage of apoptotic peripheral blood neutrophils in systemic lupus erythematosus (SLE) and to determine the relations with disease activity and neutropenia.
METHODS: Neutrophil apoptosis in SLE patients (n =50) was assessed by flow cytometry using annexin V binding and fluorescent labelled anti-fas. Rheumatoid arthritis (RA, n =20) and inflammatory bowel disease patients (IBD, n =20) were studied as disease controls.
RESULTS: The percentage of apoptotic neutrophils, determined by annexin V binding, was increased in peripheral blood of SLE patients (median = 3.25%) compared with normal healthy donors (n =20, median = 1.20%) and disease controls (RA: median = 1.15%) (IBD: median = 1.15%). SLE neutrophil apoptosis correlated positively with lupus disease activity measured by SLAM score. SLE patients with increased antibodies to dsDNA (>10 mg/ml) had increased apoptotic neutrophils. Eight of 14 neutropenic SLE patients had increased apoptotic neutrophils. Increased neutrophil fas expression compared with normal controls was observed in SLE, RA, and IBD.
CONCLUSION: Neutrophil fas expression is increased non-specifically in inflammatory disease. Increased circulating apoptotic neutrophils in SLE correlate positively with disease activity (SLAM) and may contribute to autoantigen excess including dsDNA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225817      PMCID: PMC1752888          DOI: 10.1136/ard.58.5.309

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  44 in total

1.  In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.

Authors:  H M Lorenz; M Grünke; T Hieronymus; M Herrmann; A Kühnel; B Manger; J R Kalden
Journal:  Arthritis Rheum       Date:  1997-02

Review 2.  Granulocyte clearance by apoptosis in the resolution of inflammation.

Authors:  J Savill; C Haslett
Journal:  Semin Cell Biol       Date:  1995-12

3.  Should the clinician have interest in the deregulation of apoptosis in autoimmunity?

Authors:  W B Graninger; J S Smolen
Journal:  Br J Rheumatol       Date:  1997-12

4.  CD44 regulates phagocytosis of apoptotic neutrophil granulocytes, but not apoptotic lymphocytes, by human macrophages.

Authors:  S P Hart; G J Dougherty; C Haslett; I Dransfield
Journal:  J Immunol       Date:  1997-07-15       Impact factor: 5.422

Review 5.  Apoptosis by death factor.

Authors:  S Nagata
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

Review 6.  What triggers anti-dsDNA antibodies?

Authors:  M Herrmann; O M Zoller; M Hagenhofer; R Voll; J R Kalden
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

7.  A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture.

Authors:  M van Engeland; F C Ramaekers; B Schutte; C P Reutelingsperger
Journal:  Cytometry       Date:  1996-06-01

8.  Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.

Authors:  J Drappa; A K Vaishnaw; K E Sullivan; J L Chu; K B Elkon
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

9.  Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections.

Authors:  H H Euler; P Harten; R A Zeuner; U M Schwab
Journal:  J Rheumatol       Date:  1997-11       Impact factor: 4.666

10.  Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity.

Authors:  S J Martin; D M Finucane; G P Amarante-Mendes; G A O'Brien; D R Green
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

View more
  74 in total

1.  Environment-dependent down-modulation of CD45 cell surface expression on polymorphonuclear cells.

Authors:  Ingrid Böhm
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

Review 2.  Neutrophils in the pathogenesis and manifestations of SLE.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

Review 3.  B cells in glomerulonephritis: focus on lupus nephritis.

Authors:  Menna R Clatworthy; Kenneth G C Smith
Journal:  Semin Immunopathol       Date:  2007-10-18       Impact factor: 9.623

4.  Association of apoptosis-related microsatellite polymorphisms on chromosome 1q in Taiwanese systemic lupus erythematosus patients.

Authors:  J-Y Chen; C-M Wang; S-C Lu; Y-H Chou; S-F Luo
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

5.  Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus.

Authors:  Ou Jin; Ling-yun Sun; Kang-xin Zhou; Xin-su Zhang; Xue-bing Feng; Mo-yin Mok; Chak-sing Lau
Journal:  Clin Rheumatol       Date:  2004-07-28       Impact factor: 2.980

6.  Modeling an autism risk factor in mice leads to permanent immune dysregulation.

Authors:  Elaine Y Hsiao; Sara W McBride; Janet Chow; Sarkis K Mazmanian; Paul H Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

7.  Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus.

Authors:  Magdalene Nakou; George Bertsias; Ilias Stagakis; Michael Centola; Ioannis Tassiulas; Maria Hatziapostolou; Iraklis Kritikos; George Goulielmos; Dimitrios T Boumpas; Dimitrios Iliopoulos
Journal:  PLoS One       Date:  2010-10-14       Impact factor: 3.240

8.  Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.

Authors:  M Bijl; H Bootsma; Y Van Der Geld; P C Limburg; C G M Kallenberg; M H Van Rijswijk
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

Review 9.  Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology.

Authors:  C M Cale; L Morton; D Goldblatt
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

10.  Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus - an additional mechanism to increased autoantigen load?

Authors:  A A Bengtsson; G Sturfelt; B Gullstrand; L Truedsson
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.